Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

16 Aug 2012 11:29

RNS Number : 1678K
Oryx International Growth Fund Ld
16 August 2012
 

ORYX INTERNATIONAL GROWTH FUND LIMITED

 INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2012

 Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 This interim management statement relates to the period from 1 April 2012 to 30 June 2012, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 Manager's Review

During the period under review, the FTSE Small Cap TR (£) Index returned -4.24% and the FTSE All-Share TR Index (£) returned -2.63%. Against this, the Fund's net asset value decreased by 4.5% to 292p per share.

 The Manager anticipates that a number of the holdings within the Company's portfolio will benefit from corporate activity during the next twelve months.

 Material Transactions

Since 1 April 2012, the Company has purchased for cancellation the following shares:

 24 April 2012 a total of 379,653 ordinary shares at a gross price of £2.10 per share.

Material Events

There were no material events during the quarter ended 30 June 2012.

 Report and Accounts

On 15 June 2012, the Company posted its Annual Report and Accounts for the year ended 31 March 2012, to Shareholders.

Financial Highlights

 

 

30 June 2012 

31 March 2012 

31 December 2011 

30 September 2011 

30 June 2011 

 

 

 

 

 

 

NAV

£2.93

£3.03

£2.79

£2.69

£2.96

 

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 

1.5685

 

1.5978

 

1.5541

 

1.5579

 

1.6055

 

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 30 June 2012

 

% Net Assets

Cvs Group Plc

7.85

Bioquell Plc

6.84

Gleeson (M.J.) Group Plc

6.67

Guinness Peat Group Plc

6.36

Orthoproducts Ltd

4.99

Augean Plc

4.96

Journey Group Plc

4.29

Eckoh Plc

4.28

Quarto Group Inc

4.26

Catalyst Media Group Plc

4.14

Assetco Plc

3.80

Innovation Group Plc

3.76

Sinclair Is Pharma Plc

3.23

Rpc Group Plc

2.75

Nastor Inv Ltd Zero Redeem Prefer Shares

2.61

Mecom Group Plc

2.42

Bionostics Holdings Ltd

2.40

Celsis Ag

2.09

Bavaria Industriekapital Ag

2.09

Sinav Limited

1.99

81.78

 

 

The financial information for the quarter ended 30 June 2012 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUCPRUPPGUQ
Date   Source Headline
25th Oct 202112:09 pmRNSTransaction in Own Shares
11th Oct 202110:25 amRNSNet Asset Value(s)
23rd Sep 20214:32 pmRNSMajor liquidity events totalling £43 million
8th Sep 20212:13 pmRNSNet Asset Value(s)
27th Aug 202112:30 pmRNSResult of Annual General Meeting
9th Aug 20213:12 pmRNSNet Asset Value(s)
27th Jul 20216:00 pmRNSNotice of AGM
14th Jul 202111:45 amRNSNet Asset Value(s)
8th Jul 202111:42 amRNSAnnual Financial Report
9th Jun 20218:24 amRNSNet Asset Value(s)
3rd Jun 20212:44 pmRNSHolding(s) in Company - Replacement
3rd Jun 202112:51 pmRNSHolding(s) in Company
3rd Jun 20217:02 amRNSHolding(s) in Company
3rd Jun 20217:01 amRNSHolding(s) in Company
3rd Jun 20217:00 amRNSHolding(s) in Company
13th May 202111:21 amRNSNet Asset Value(s)
14th Apr 202111:42 amRNSNet Asset Value(s)
24th Mar 202110:26 amRNSHolding(s) in Company
22nd Mar 20216:27 pmRNSHolding(s) in Company
12th Mar 20213:37 pmRNSHolding(s) in Company
12th Mar 202111:01 amRNSNet Asset Value(s)
5th Mar 20219:02 amRNSHolding(s) in Company
4th Mar 202112:30 pmRNSHolding(s) in Company
1st Mar 20211:49 pmRNSTotal Voting Rights
26th Feb 20215:04 pmRNSHolding(s) in Company
25th Feb 20214:21 pmRNSHolding(s) in Company
17th Feb 20211:11 pmRNSHolding(s) in Company
12th Feb 202112:25 pmRNSTransaction in Own Shares
11th Feb 20216:00 pmRNSHolding(s) in Company
11th Feb 202110:49 amRNSNet Asset Value(s)
22nd Jan 20214:00 pmRNSHolding(s) in Company
22nd Jan 202111:09 amRNSHolding(s) in Company
20th Jan 20214:25 pmRNSNet Asset Value(s)
20th Jan 20219:50 amRNSHolding(s) in Company
18th Jan 20213:32 pmRNSHolding(s) in Company
15th Jan 20211:23 pmRNSHolding(s) in Company
4th Jan 20214:28 pmRNSTR-1: Notification of major holdings
4th Jan 20211:38 pmRNSTR1: Notification of major shareholding
4th Jan 202111:26 amRNSHoldings in Company
4th Jan 20217:30 amRNSHolding(s) in Company
31st Dec 20201:04 pmRNSTR-1
23rd Dec 202012:43 pmRNSHolding(s) in Company
21st Dec 20203:57 pmRNSNet Asset Value(s)
11th Dec 20201:05 pmRNSHolding(s) in Company
10th Dec 20201:55 pmRNSHalf-year Report
3rd Dec 20205:08 pmRNSTR-1
1st Dec 20204:41 pmRNSHolding(s) in Company
26th Nov 20201:08 pmRNSTR-1
25th Nov 20202:06 pmRNSHolding(s) in Company
23rd Nov 202012:25 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.